Stock Watch: InvestorSoup.com Issues Market Alert for Keryx Pharmaceuticals Inc. - GlobeNewsWire (press release) PDF Print
GlobeNewsWire (press release)Zerenex is in phase II clinical development for the treatment of hyperphosphatemia (elevated phosphate levels) in patients with end stage renal disease

... read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.